John Hopkins University is quickly testing a passive-antibody therapy to help battle Covid-19, a method used since the 1890s. (Read more at John Hopkins hub)
The Trump Administration’s FDA gave emergency authorization for testing on March 24.
Old Tactic vs. New Disease
